NPS R-568: Will begin in the next few weeks Phase I trials

NPS Pharmaceuticals Inc., Salt Lake City Product: NPS R-568 mimic of calcium that activates the calcium receptor in the parathyroid gland Indication: Hyperparathyroidism Status: Will begin in the next...